PVI
GILD icon

Partners Value Investments’s Gilead Sciences GILD Stock Holding History

Partners Value Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-68,000
Closed -$4.87M – 12
2017
Q4 		$4.87M Hold
68,000
– – 0.73% 13
2017
Q3 		$5.51M Hold
68,000
– – 0.82% 16
2017
Q2 		$4.81M Hold
68,000
– – 0.77% 14
2017
Q1 		$4.64M Buy
+68,000
New +$4.78M 0.78% 14

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Partners Value Investments's GILD Position: Q1 2018 in Review

Partners Value Investments sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 68,000 shares — an estimated $4.87M sold.

Partners Value Investments first reported a position in GILD in Q1 2017 and held it in 4 quarters. The position peaked at $5.51M in Q3 2017. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Partners Value Investments reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Partners Value Investments sold 68,000 Gilead Sciences shares in Q1 2018, an estimated $4.87M.
  • Partners Value Investments first reported a position in Gilead Sciences in Q1 2017 and held it in 4 quarters.
  • Partners Value Investments's Gilead Sciences position peaked at $5.51M in Q3 2017.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Partners Value Investments's 13F filing for Q1 2018, filed 14 May 2018.